Resumen

ALVAREZ-VERA, José L. et al. Mexican Consensus on Hodgkin’s Lymphoma. Gac. Méd. Méx [online]. 2021, vol.157, suppl.2, pp.S1-S18.  Epub 25-Abr-2022. ISSN 2696-1288.  https://doi.org/10.24875/gmm.m21000500.

Hodgkin’s lymphoma is due to the clonal transformation of cells originating from B lymphocytes, generating the pathognomonic binucleate Reed-Sternberg cells. Hodgkin’s lymphoma is a B cell disease with a bimodal distribution, with higher incidence in adolescence and the third decade of life, showing a second peak in people over 55 years of age. Classic Hodgkin lymphoma cells routinely undergo gene expression reprogramming, as they lose the expression of most of the typical B-cell genes and acquire the expression of multiple genes that are typical of other types of cells in the immune system. The treatment algorithm will depend on whether it is classic or predominantly lymphocytic HL, if it is early stage with unfavorable prognostic markers or not, the initial management regimen, and whether there is bulky disease, among the most relevant variables.

Palabras llave : Reed sternberg; Inmunohistochemical; Brentuximab; Quimioterapy; Deauville.

        · resumen en Español     · texto en Español     · Español ( pdf )